DK1463725T3 - Fremgangsmåde og intermediater til pyridazinon antidiabetiske midler - Google Patents

Fremgangsmåde og intermediater til pyridazinon antidiabetiske midler

Info

Publication number
DK1463725T3
DK1463725T3 DK03700018T DK03700018T DK1463725T3 DK 1463725 T3 DK1463725 T3 DK 1463725T3 DK 03700018 T DK03700018 T DK 03700018T DK 03700018 T DK03700018 T DK 03700018T DK 1463725 T3 DK1463725 T3 DK 1463725T3
Authority
DK
Denmark
Prior art keywords
pyridazinone
intermediates
antidiabetic agents
antidiabetic
agents
Prior art date
Application number
DK03700018T
Other languages
English (en)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1463725T3 publication Critical patent/DK1463725T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03700018T 2002-01-09 2003-01-03 Fremgangsmåde og intermediater til pyridazinon antidiabetiske midler DK1463725T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34767902P 2002-01-09 2002-01-09

Publications (1)

Publication Number Publication Date
DK1463725T3 true DK1463725T3 (da) 2005-11-21

Family

ID=23364775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03700018T DK1463725T3 (da) 2002-01-09 2003-01-03 Fremgangsmåde og intermediater til pyridazinon antidiabetiske midler

Country Status (22)

Country Link
US (1) US6759534B2 (da)
EP (1) EP1463725B1 (da)
JP (1) JP2005514421A (da)
KR (1) KR100604502B1 (da)
CN (1) CN1269814C (da)
AR (1) AR038267A1 (da)
AT (1) ATE302201T1 (da)
AU (1) AU2003200847A1 (da)
BR (1) BR0306730A (da)
CA (1) CA2472331A1 (da)
DE (1) DE60301324T2 (da)
DK (1) DK1463725T3 (da)
ES (1) ES2246464T3 (da)
HU (1) HUP0500031A2 (da)
IL (1) IL162594A0 (da)
MX (1) MXPA04005646A (da)
PL (1) PL371258A1 (da)
PT (1) PT1463725E (da)
RU (1) RU2278116C2 (da)
TW (1) TWI250980B (da)
WO (1) WO2003057691A1 (da)
ZA (1) ZA200404798B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途
CN105732552B (zh) * 2016-04-12 2017-12-01 天津师范大学 2位或3‑位硫代苯并呋喃化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328770A1 (de) * 1983-08-10 1985-02-28 Basf Ag, 6700 Ludwigshafen Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.

Also Published As

Publication number Publication date
ZA200404798B (en) 2006-02-22
CN1615307A (zh) 2005-05-11
WO2003057691A1 (en) 2003-07-17
IL162594A0 (en) 2005-11-20
ATE302201T1 (de) 2005-09-15
RU2004121026A (ru) 2006-01-10
MXPA04005646A (es) 2004-12-06
KR100604502B1 (ko) 2006-07-25
DE60301324D1 (de) 2005-09-22
EP1463725B1 (en) 2005-08-17
PL371258A1 (en) 2005-06-13
US6759534B2 (en) 2004-07-06
BR0306730A (pt) 2004-12-21
RU2278116C2 (ru) 2006-06-20
TW200302098A (en) 2003-08-01
DE60301324T2 (de) 2006-05-24
PT1463725E (pt) 2005-10-31
EP1463725A1 (en) 2004-10-06
TWI250980B (en) 2006-03-11
AU2003200847A1 (en) 2003-07-24
US20030162969A1 (en) 2003-08-28
HUP0500031A2 (hu) 2005-04-28
CN1269814C (zh) 2006-08-16
HK1072598A1 (en) 2005-09-02
AR038267A1 (es) 2005-01-12
ES2246464T3 (es) 2006-02-16
CA2472331A1 (en) 2003-07-17
JP2005514421A (ja) 2005-05-19
KR20040072710A (ko) 2004-08-18

Similar Documents

Publication Publication Date Title
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
DK1644384T3 (da) Fremgangsmåde og mellemprodukter til syntese af entecavir
DK1581487T3 (da) Fremgangsmåder og forbindelser til produktion af dipeptidylpeptidase iv-inhibitorer og mellemprodukter deraf
NO20022286D0 (no) Fasesementeringsverktöy for tynne hull og fremgangsmåte
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
NO20051904D0 (no) Setteverktoy for apent vann og lasehylse-enhet
IS2738B (is) Tæki til þess að hreinsa bræddan málm
DK1505963T3 (da) Hepatitis C-inhibitorer
DE60319787D1 (de) Montageverfahren und -vorrichtung
NO20044662L (no) Forbindelser, blandinger og fremgangsmater
FI20022276L (fi) Teräsovitelma
IS6401A (is) Efnafræðilegar aðferðir og milliefni
GB0203933D0 (en) Portable dummy sterilizer
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
FI20020780A7 (fi) Menetelmä kullan talteenottamiseksi
GB0222909D0 (en) Novel process and intermediates
DK1578738T3 (da) Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf
IL168837A (en) Synthesis of amines and intermediates for their synthesis
GB0222912D0 (en) Novel process and intermediates
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
DK1662867T3 (da) Insekticid-forbindelser og fremgangsmåder til valg deraf
ATA14732002A (de) Spannvorrichtung
DK1639107T3 (da) Forbedrede proteaser og fremgangsmåder til fremstilling deraf
AU2003258941A8 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
ITMI20020198A0 (it) (per)aloeteri